LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of type 2 diabetes. It helps control blood sugar by increasing insulin release after meals and reducing glucose production in the liver. LINANTA 5 is commonly prescribed to improve glycemic control, support stable HbA1c levels, and help patients maintain better long-term diabetes management when combined with diet and exercise
Related products
SITPIN D 10/100
Composition: Sitagliptin 100 mg + Dapagliflozin 10 mg. View SITPIN D 10/100 details or enquire...
SITAMATA 50- 1000
Compositins : Each Film Coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP Eq to Sitagliptin...
MUCINIL TAB
COMPOSITION : N acetyl cysteine 150 mg and taurine 500 mg
GLIPDIP M
GLIPDIP M is used for effective management of type 2 diabetes mellitus. Each tablet contains...
EVOGLIX
EVOGLIX M 500 Tablet is a combination medicine used to manage type 2 diabetes effectively....
DUET ACT 4
DUET ACT 4 Tablet is a combination medicine used for effective management of type 2...
DUET ACT 3
DUET ACT 3 Tablet is a combination medicine used for managing type 2 diabetes. It...
DUET ACT 2
DUET ACT 2 combines Glimepiride 2 mg with Metformin 500 mg (SR) for better blood...
